DVA vs RNXT · P/E 14, rev $12.82B vs rev $266.0K
DaVita HealthCare Partners Inc (DVA) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the DVA and RNXT stock pages for the full models.
Not investment advice.